Long ‐term efficacy and safety of add‐on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors

ConclusionAdding tacrolimus onto anti‐TNF therapy is a promising therapeutic option with sustained benefit for refractory RA patients despite treatment with anti‐TNF therapy combined with methotrexate.

Source: APLAR Journal of Rheumatology - January 4, 2018 Category: Rheumatology Authors: Taio Naniwa, Shiho Iwagaitsu, Mikiko Kajiura Tags: Original Article Source Type: research